SCHEMBL18917657

SCHEMBL18917657

FC(F)C(F)(F)OC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)F

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.35
TSHR P16473 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22761469 0.92 KDM4E (0.37) KDM4ETSHRTDP1
SCHEMBL28409780 0.81 KDM4E (0.30) KDM4ETSHRTDP1
SCHEMBL15546794 0.80 LMNA (0.32)
SCHEMBL8823265 0.79
SCHEMBL17124986 0.78 KDM4E (0.34) KDM4ETSHRTDP1
SCHEMBL18917656 0.78
SCHEMBL29988610 0.78 MEN1 (0.30)
SCHEMBL16480256 0.76 KDM4E (0.34) KDM4ETSHRTDP1
SCHEMBL21045063 0.75
SCHEMBL498059 0.74 KDM4E (0.43) KDM4ETSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10243234-B2 Secondary battery NEC CORPORATION (JP) 2019-03-26 US claimed
US-20170352908-A1 SECONDARY BATTERY NEC CORPORATION (JP) 2017-12-07 US claimed
CN-110637389-B Lithium ion secondary battery 日本电气株式会社 2023-02-21 CN disclosed
US-11581581-B2 Lithium ion secondary battery NEC CORPORATION (JP) 2023-02-14 US disclosed
CN-109690860-B Lithium secondary battery 日本电气株式会社 2022-11-22 CN disclosed
CN-110036521-B Lithium ion secondary battery 日本电气株式会社 2022-11-15 CN disclosed
US-20220166069-A1 Non-Aqueous Electrolyte Solution for Lithium Secondary Battery and Lithium Secondary Battery Including the Same LG ENERGY SOLUTION, LTD. (KR) 2022-05-26 US disclosed
US-11329321-B2 Lithium ion secondary battery NEC CORPORATION (JP) 2022-05-10 US disclosed
EP-3944394-A1 NON-AQUEOUS ELECTROLYTE FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY COMPRISING SAME LG ENERGY SOLUTION, LTD. (KR) 2022-01-26 EP disclosed
CN-113646944-A Nonaqueous electrolyte solution for lithium secondary battery and lithium secondary battery comprising same 株式会社LG新能源 2021-11-12 CN disclosed
US-20210057721-A1 LITHIUM ION SECONDARY BATTERY NEC CORPORATION (JP) 2021-02-25 US disclosed
US-20200106134-A1 ELECTROLYTE SOLUTION FOR LITHIUM ION SECONDARY BATTERY AND LITHIUM ION SECONDARY BATTERY USING SAME NEC CORPORATION (JP) 2020-04-02 US disclosed
US-20200091559-A1 LITHIUM ION SECONDARY BATTERY NEC CORPORATION (JP) 2020-03-19 US disclosed
CN-110720156-A Lithium ion secondary battery 日本电气株式会社 2020-01-21 CN disclosed
CN-110637389-A Lithium ion secondary battery 日本电气株式会社 2019-12-31 CN disclosed
CN-110637388-A Electrolyte for lithium ion secondary battery and lithium ion secondary battery using same 日本电气株式会社 2019-12-31 CN disclosed
US-10381686-B2 Electrolyte solution and secondary battery using same NEC CORPORATION (JP) 2019-08-13 US disclosed
US-10243234-B2 Secondary battery NEC CORPORATION (JP) 2019-03-26 US disclosed
US-20170352908-A1 SECONDARY BATTERY NEC CORPORATION (JP) 2017-12-07 US disclosed
US-20170162910-A1 ELECTROLYTE SOLUTION AND SECONDARY BATTERY USING SAME NEC CORPORATION (JP) 2017-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220166069-A1 Non-Aqueous Electrolyte Solution for Lithium Secondary Battery and Lithium Secondary Battery Including the Same FGF23, LEF1, MLLT3 KDM4E 744/4885TSHR 2303/4885TDP1 1750/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.